Ghost Tree Capital, LLC - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 189 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ghost Tree Capital, LLC ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,667,200
-79.2%
80,000
-51.5%
0.55%
-74.0%
Q2 2020$7,998,000
-60.1%
165,000
-78.0%
2.11%
-49.3%
Q2 2019$20,048,000
-17.0%
750,000
-16.7%
4.16%
-34.1%
Q1 2019$24,165,000
+1095.7%
900,000
+620.0%
6.31%
+761.3%
Q4 2018$2,021,000
-90.3%
125,000
-87.5%
0.73%
-83.4%
Q3 2018$20,760,000
+154.1%
1,000,000
+86.9%
4.41%
+83.5%
Q2 2018$8,169,000
-9.1%
535,000
+33.8%
2.40%
+32.2%
Q1 2018$8,988,000
+118.9%
400,000
+267.0%
1.82%
+108.5%
Q3 2017$4,106,000
-46.5%
109,000
-60.4%
0.87%
-45.3%
Q2 2017$7,670,000
-60.0%
275,000
-50.6%
1.59%
-55.4%
Q1 2017$19,157,000
+47.6%
557,200
+23.8%
3.57%
+14.3%
Q4 2016$12,978,000
+104.0%
450,000
+125.0%
3.12%
+202.6%
Q3 2016$6,362,000
-46.5%
200,000
-52.9%
1.03%
-84.7%
Q1 2016$11,883,000
+33.3%
425,000
+70.0%
6.72%
+84.3%
Q4 2015$8,913,000
+127.9%
250,000
+108.3%
3.65%
+419.1%
Q1 2015$3,911,000120,0000.70%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Finepoint Capital LP 556,553$11,598,5655.78%
Baker Brothers Advisors 42,864,612$893,298,5145.15%
RTW INVESTMENTS, LP 11,576,537$241,255,0315.09%
Palo Alto Investors LP 2,405,793$50,136,7264.74%
Birchview Capital, LP 240,400$5,009,9364.26%
EcoR1 Capital, LLC 5,991,479$124,862,4224.21%
EMERALD ADVISERS, LLC 1,681,052$35,033,1241.70%
EMERALD MUTUAL FUND ADVISERS TRUST 1,303,988$27,175,1101.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 179,702$3,739,5991.26%
SECTOR GAMMA AS 179,785$3,746,7190.96%
View complete list of ACADIA PHARMACEUTICALS INC shareholders